Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 3/2018

03.01.2018 | Editorial

Benign Tumors of the Pancreas—Radical Surgery Versus Parenchyma-Sparing Local Resection—the Challenge Facing Surgeons

verfasst von: Hans G. Beger

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Pancreaticoduodenectomy and left-sided pancreatectomy are the surgical treatment standards for tumors of the pancreas. Surgeons, who are requested to treat patients with benign tumors, using standard oncological resections, face the challenge of sacrificing pancreatic and extra-pancreatic tissue. Tumor enucleation, pancreatic middle segment resection and local, duodenum-preserving pancreatic head resections are surgical procedures increasingly used as alternative treatment modalities compared to classical pancreatic resections. Use of local resection procedures for cystic neoplasms and neuro-endocrine tumors of the pancreas (panNETs) is associated with an improvement of procedure-related morbidity, when compared to classical Whipple OP (PD) and left-sided pancreatectomy (LP). The procedure-related advantages are a 90-day mortality below 1% and a low level of POPF B+C rates. Most importantly, the long-term benefits of the use of local surgical procedures are the preservation of the endocrine and exocrine pancreatic functions. PD performed for benign tumors on preoperative normo-glycemic patients is followed by the postoperative development of new onset of diabetes mellitus (NODM) in 4 to 24% of patients, measured by fasting blood glucose and/or oral/intravenous glucose tolerance test, according to the criteria of the international consensus guidelines. Persistence of new diabetes mellitus during the long-term follow-up after PD for benign tumors is observed in 14.5% of cases and after surgery for malignant tumors in 15.5%. Pancreatic exocrine insufficiency after PD is found in the long-term follow-up for benign tumors in 25% and for malignant tumors in 49%. Following LP, 14–31% of patients experience postoperatively NODM; many of the patients subsequently change to insulin-dependent diabetes mellitus (IDDM). The decision-making for cystic neoplasms and panNETs of the pancreas should be guided by the low surgical risk and the preservation of pancreatic metabolic functions when undergoing a limited, local, tissue-sparing procedure.
Literatur
1.
Zurück zum Zitat Birkmeyer JD, Finlayson SR, Tosteson AN, Sharp SM, Warshaw AL, Fisher ES. Effect of hospital volume on in-hospital mortality with pancreaticoduodenectomy. Surgery 1999;125:250–256CrossRefPubMed Birkmeyer JD, Finlayson SR, Tosteson AN, Sharp SM, Warshaw AL, Fisher ES. Effect of hospital volume on in-hospital mortality with pancreaticoduodenectomy. Surgery 1999;125:250–256CrossRefPubMed
2.
Zurück zum Zitat Dudekula A, Munigala S, Zureikat AH, Yadav D. Operative Trends for Pancreatic Diseases in the USA: Analysis of the Nationwide Inpatient Sample from 1998-2011.J Gastrointest Surg. 2016;20:803–811CrossRefPubMed Dudekula A, Munigala S, Zureikat AH, Yadav D. Operative Trends for Pancreatic Diseases in the USA: Analysis of the Nationwide Inpatient Sample from 1998-2011.J Gastrointest Surg. 2016;20:803–811CrossRefPubMed
3.
Zurück zum Zitat Trede M, Schwall G, Saeger HD. Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg 1990;211:447–458.CrossRefPubMedPubMedCentral Trede M, Schwall G, Saeger HD. Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg 1990;211:447–458.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Beger HG, Gansauge F, Schwarz M, Poch B. Pancreatic head resection: the risk for local and systemic complications in 1315 patients—a monoinstitutional experience. Am J Surg 2007;194:S16-S19.CrossRef Beger HG, Gansauge F, Schwarz M, Poch B. Pancreatic head resection: the risk for local and systemic complications in 1315 patients—a monoinstitutional experience. Am J Surg 2007;194:S16-S19.CrossRef
5.
Zurück zum Zitat Cameron JL, He J. Two thousand consecutive pancreaticoduodenectomies. Journal of the Am Coll Surg. 2015; 220:530–536.CrossRef Cameron JL, He J. Two thousand consecutive pancreaticoduodenectomies. Journal of the Am Coll Surg. 2015; 220:530–536.CrossRef
6.
Zurück zum Zitat Are C, Afuh C, Ravipati L, et al. Preoperative nomogram to predict risk of perioperative mortality following pancreatic resections for malignancy. J Gastrointest Surg. 2009;13:2152–2162.CrossRefPubMed Are C, Afuh C, Ravipati L, et al. Preoperative nomogram to predict risk of perioperative mortality following pancreatic resections for malignancy. J Gastrointest Surg. 2009;13:2152–2162.CrossRefPubMed
7.
Zurück zum Zitat Schneider EB, Ejaz A, Spolverato G. et al. Hospital volume and patient outcomes in hepato-pancreatico-biliary surgery: is assessing differences in mortality enough?. J Gastrointest Surg. 2014;18:2105–2115.CrossRefPubMed Schneider EB, Ejaz A, Spolverato G. et al. Hospital volume and patient outcomes in hepato-pancreatico-biliary surgery: is assessing differences in mortality enough?. J Gastrointest Surg. 2014;18:2105–2115.CrossRefPubMed
8.
Zurück zum Zitat Keck T, Wellner UF, Bahra M, et al. Pancreatogastrostomy versus pancreatojejunostomy for RECOnstruction after PANCreatoduodenectomy (RECOPANC, DRKS 00000767): perioperative and long-term results of a multicenter randomized controlled trial. Ann Surg 2016;263: 440–449CrossRefPubMedPubMedCentral Keck T, Wellner UF, Bahra M, et al. Pancreatogastrostomy versus pancreatojejunostomy for RECOnstruction after PANCreatoduodenectomy (RECOPANC, DRKS 00000767): perioperative and long-term results of a multicenter randomized controlled trial. Ann Surg 2016;263: 440–449CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Venkat R, Edil BH, Schulick RD, Lidor AO, Makary MA, Wolfgang CL. Laparoscopic distal pancreatectomy is associated with significantly less overall morbidity compared to the open technique: a systematic review and meta-analysis. Ann Surg. 2012;255:1048–59CrossRefPubMed Venkat R, Edil BH, Schulick RD, Lidor AO, Makary MA, Wolfgang CL. Laparoscopic distal pancreatectomy is associated with significantly less overall morbidity compared to the open technique: a systematic review and meta-analysis. Ann Surg. 2012;255:1048–59CrossRefPubMed
11.
Zurück zum Zitat Vijan SS, Ahmed KA, Harmsen WS, Que FG, Reid-Lombardo KM, Nagorney DM, Donohue JH, Farnell MB, Kendrick ML.Laparoscopic vs open distal pancreatectomy: a single-institution comparative study. Arch Surg 2010;145:616–621CrossRefPubMed Vijan SS, Ahmed KA, Harmsen WS, Que FG, Reid-Lombardo KM, Nagorney DM, Donohue JH, Farnell MB, Kendrick ML.Laparoscopic vs open distal pancreatectomy: a single-institution comparative study. Arch Surg 2010;145:616–621CrossRefPubMed
12.
Zurück zum Zitat Jilesen AP, van Eijck CH, In't Hof KH, van Dieren S, Gouma DJ, van Dijkum EJ. Postoperative Complications, In-Hospital Mortality and 5-Year Survival After Surgical Resection for Patients with a Pancreatic Neuroendocrine Tumor: A Systematic Review. World J Surg. 2016;40:729–48. .CrossRefPubMed Jilesen AP, van Eijck CH, In't Hof KH, van Dieren S, Gouma DJ, van Dijkum EJ. Postoperative Complications, In-Hospital Mortality and 5-Year Survival After Surgical Resection for Patients with a Pancreatic Neuroendocrine Tumor: A Systematic Review. World J Surg. 2016;40:729–48. .CrossRefPubMed
13.
Zurück zum Zitat Nakamura M, Nakashima H. Laparoscopic distal pancreatectomy and pancreatoduodenectomy: is it worthwhile? A meta-analysis of laparoscopic pancreatectomy. J Hepatobiliary Pancreat Sci. 2013;20:421–428.CrossRefPubMed Nakamura M, Nakashima H. Laparoscopic distal pancreatectomy and pancreatoduodenectomy: is it worthwhile? A meta-analysis of laparoscopic pancreatectomy. J Hepatobiliary Pancreat Sci. 2013;20:421–428.CrossRefPubMed
14.
Zurück zum Zitat Jin T, Altaf K, Xiong JJ, −Huang W, Javed MA, Mai G. et al. A systematic review and meta-analysis of studies comparing laparoscopic and open distal pancreatectomy. HPB 2012;14(11):711–724CrossRefPubMedPubMedCentral Jin T, Altaf K, Xiong JJ, −Huang W, Javed MA, Mai G. et al. A systematic review and meta-analysis of studies comparing laparoscopic and open distal pancreatectomy. HPB 2012;14(11):711–724CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Daouadi M, Zureikat AH, Zenati MS, Choudry H, Tsung A, et al. Robot-assisted minimally invasive distal pancreatectomy is superior to the laparoscopic technique. Ann Surg. 2013;257:128–132CrossRefPubMed Daouadi M, Zureikat AH, Zenati MS, Choudry H, Tsung A, et al. Robot-assisted minimally invasive distal pancreatectomy is superior to the laparoscopic technique. Ann Surg. 2013;257:128–132CrossRefPubMed
16.
Zurück zum Zitat Schmidt CM. Is surgical intervention for cystic neoplasms of the pancreas being underutilized? J Gastrointest Surg. 2014;18:184–6.CrossRefPubMed Schmidt CM. Is surgical intervention for cystic neoplasms of the pancreas being underutilized? J Gastrointest Surg. 2014;18:184–6.CrossRefPubMed
17.
Zurück zum Zitat Finkelstein P, Sharma R, Picado O, Gadde R, Stuart H et al. Pancreatic Neuroendocrine Tumors (panNETs): Analysis of Overall Survival of Nonsurgical Management Versus Surgical Resection. J Gastrointest Surg 2017;21:855-866 Aug 23 online Finkelstein P, Sharma R, Picado O, Gadde R, Stuart H et al. Pancreatic Neuroendocrine Tumors (panNETs): Analysis of Overall Survival of Nonsurgical Management Versus Surgical Resection. J Gastrointest Surg 2017;21:855-866 Aug 23 online
19.
Zurück zum Zitat Ferrara MJ, Lohse C, Kudva YC, Farnell MB, Que FG, Reid-Lombardo KM, Donohue JH, Nagorney DM, Chari ST, Vege SS, Kendrick ML. Immediate post-resection diabetes mellitus after pancreaticoduodenectomy: incidence and risk factors. HPB 2013;15:170–174CrossRefPubMedPubMedCentral Ferrara MJ, Lohse C, Kudva YC, Farnell MB, Que FG, Reid-Lombardo KM, Donohue JH, Nagorney DM, Chari ST, Vege SS, Kendrick ML. Immediate post-resection diabetes mellitus after pancreaticoduodenectomy: incidence and risk factors. HPB 2013;15:170–174CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Seiler CA, Wagner M, Bachmann T, Redaelli CA, Schmied B, Uhl W, Friess H, Büchler MW. Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection-long term results. Br J Surg 2005;92:547–56CrossRefPubMed Seiler CA, Wagner M, Bachmann T, Redaelli CA, Schmied B, Uhl W, Friess H, Büchler MW. Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection-long term results. Br J Surg 2005;92:547–56CrossRefPubMed
21.
Zurück zum Zitat Leal JN, Kingham TP, D'Angelica MI, DeMatteo RP, Jarnagin WR, Kalin MF, Allen PJ. Intraductal Papillary Mucinous Neoplasms and the Risk of Diabetes Mellitus in Patients Undergoing Resection Versus Observation. J Gastrointest Surg 2015;19:1974–1981.CrossRefPubMedPubMedCentral Leal JN, Kingham TP, D'Angelica MI, DeMatteo RP, Jarnagin WR, Kalin MF, Allen PJ. Intraductal Papillary Mucinous Neoplasms and the Risk of Diabetes Mellitus in Patients Undergoing Resection Versus Observation. J Gastrointest Surg 2015;19:1974–1981.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat De Bruijn KM, van Eijck CH. New-onset diabetes after distal pancreatectomy: a systematic review. Ann Surg 2015;261:854–61.CrossRefPubMed De Bruijn KM, van Eijck CH. New-onset diabetes after distal pancreatectomy: a systematic review. Ann Surg 2015;261:854–61.CrossRefPubMed
23.
Zurück zum Zitat Kang, J. S., Jang, J. Y., Kang, M. J., Kim, E., Jung, W., Chang, J.et al. Endocrine Function Impairment After Distal Pancreatectomy: Incidence and Related Factors. World J Surg 2016; 40:440–446.CrossRefPubMed Kang, J. S., Jang, J. Y., Kang, M. J., Kim, E., Jung, W., Chang, J.et al. Endocrine Function Impairment After Distal Pancreatectomy: Incidence and Related Factors. World J Surg 2016; 40:440–446.CrossRefPubMed
24.
Zurück zum Zitat Kumar AF, Gruessner RW, Seaquist ER. Risk of glucose intolerance and diabetes in hemipancreatectomized donors selected for normal preoperative glucose metabolism. Diabetes Care 2008;31:1639–1643.CrossRefPubMedPubMedCentral Kumar AF, Gruessner RW, Seaquist ER. Risk of glucose intolerance and diabetes in hemipancreatectomized donors selected for normal preoperative glucose metabolism. Diabetes Care 2008;31:1639–1643.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Kendall DM, Sutherland DE, Najarian JS, Goetz FC, Robertson RP. Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J Med. 1990;322:898–903CrossRefPubMed Kendall DM, Sutherland DE, Najarian JS, Goetz FC, Robertson RP. Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J Med. 1990;322:898–903CrossRefPubMed
26.
Zurück zum Zitat Ohtsuka T, Kono H, Tanabe R, Nagayoshi Y, Mori Y, et. al. Follow-up study after resection of intraductal papillary mucinous neoplasm of the pancreas; special references to the multifocal lesions and development of ductal carcinoma in the remnant pancreas. Am J Surg. 2012;204:44–8. Ohtsuka T, Kono H, Tanabe R, Nagayoshi Y, Mori Y, et. al. Follow-up study after resection of intraductal papillary mucinous neoplasm of the pancreas; special references to the multifocal lesions and development of ductal carcinoma in the remnant pancreas. Am J Surg. 2012;204:44–8.
27.
Zurück zum Zitat Postlewait LM, Ethun CG, McInnis MR, Merchant N, Parikh A, et al. Association of Preoperative Risk Factors With Malignancy in Pancreatic Mucinous Cystic Neoplasms: A Multicenter Study. JAMA Surg. 2017;152:19–25CrossRefPubMedPubMedCentral Postlewait LM, Ethun CG, McInnis MR, Merchant N, Parikh A, et al. Association of Preoperative Risk Factors With Malignancy in Pancreatic Mucinous Cystic Neoplasms: A Multicenter Study. JAMA Surg. 2017;152:19–25CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Tanaka M, Fernández-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology, 2012;12:183–197CrossRefPubMed Tanaka M, Fernández-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology, 2012;12:183–197CrossRefPubMed
29.
Zurück zum Zitat Salvia R, Malleo G, Marchegiani G, et al. Pancreatic resections for cystic neoplasms: From the surgeon’s presumption to the pathologist’s reality. Surgery 2012;152:S135–142CrossRefPubMed Salvia R, Malleo G, Marchegiani G, et al. Pancreatic resections for cystic neoplasms: From the surgeon’s presumption to the pathologist’s reality. Surgery 2012;152:S135–142CrossRefPubMed
30.
Zurück zum Zitat Zaruba P, Dvořáková T, Zavada F, et al. [Is accurate preoperative assessment of pancreatic cystic lesions possible?]. Rozhledy v chirurgii: mesicnik Ceskoslovenske chirurgicke spolecnosti, 2013;92:708–714 Zaruba P, Dvořáková T, Zavada F, et al. [Is accurate preoperative assessment of pancreatic cystic lesions possible?]. Rozhledy v chirurgii: mesicnik Ceskoslovenske chirurgicke spolecnosti, 2013;92:708–714
31.
Zurück zum Zitat Donahue TR, Hines OJ, Farrell JJ, et al. Cystic neoplasms of the pancreas: results of 114 cases. Pancreas 2010;39:1271–1276CrossRefPubMed Donahue TR, Hines OJ, Farrell JJ, et al. Cystic neoplasms of the pancreas: results of 114 cases. Pancreas 2010;39:1271–1276CrossRefPubMed
32.
33.
Zurück zum Zitat Tanaka M, Current best practice and controversies in the follow up of patients with asymptomatic branch duct IPMN of the pancreas. HPB. 2016;18:709–11.CrossRefPubMedPubMedCentral Tanaka M, Current best practice and controversies in the follow up of patients with asymptomatic branch duct IPMN of the pancreas. HPB. 2016;18:709–11.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Sahani DV, Kadavigere R, Saokar A, et al. Cystic Pancreatic Lesions: A Simple Imaging-based Classification System for Guiding Management 1. Radiographics Rev Publ Radiol Soc 2005;25:1471–1484 Sahani DV, Kadavigere R, Saokar A, et al. Cystic Pancreatic Lesions: A Simple Imaging-based Classification System for Guiding Management 1. Radiographics Rev Publ Radiol Soc 2005;25:1471–1484
35.
Zurück zum Zitat Farrell JJ, Fernández-del Castillo C. Pancreatic cystic neoplasms: management and unanswered questions. Gastroenterology. 2013;144:1303–1315CrossRefPubMed Farrell JJ, Fernández-del Castillo C. Pancreatic cystic neoplasms: management and unanswered questions. Gastroenterology. 2013;144:1303–1315CrossRefPubMed
36.
Zurück zum Zitat Lennon AM, Wolfgang C. Cystic neoplasms of the pancreas. J Gastroentest Surg 2013;17:645–653CrossRef Lennon AM, Wolfgang C. Cystic neoplasms of the pancreas. J Gastroentest Surg 2013;17:645–653CrossRef
37.
Zurück zum Zitat Kunz PL, Reidy-Lagunes D, Anthony LB, et al. Consensus guidelines for the management and treatment of neuroendocrine tumors. Pancreas 2013; 42:557–577.CrossRefPubMedPubMedCentral Kunz PL, Reidy-Lagunes D, Anthony LB, et al. Consensus guidelines for the management and treatment of neuroendocrine tumors. Pancreas 2013; 42:557–577.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Ramage JK, Davies AH, Ardill J, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut. 2005;54 Suppl 4:iv1–16PubMedPubMedCentral Ramage JK, Davies AH, Ardill J, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut. 2005;54 Suppl 4:iv1–16PubMedPubMedCentral
39.
Zurück zum Zitat Gratian L, Pura J, Dinan M, Roman S, Reed S, Sosa JA. Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States. Ann Surg Oncol 2014;21:3515–21CrossRefPubMedPubMedCentral Gratian L, Pura J, Dinan M, Roman S, Reed S, Sosa JA. Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States. Ann Surg Oncol 2014;21:3515–21CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Halsted WS. Contributions to the surgery of the bile passages, especially of the common bile-duct. The Boston Medical and Surgical Journal, 1899:141; 645–654. Halsted WS. Contributions to the surgery of the bile passages, especially of the common bile-duct. The Boston Medical and Surgical Journal, 1899:141; 645–654.
41.
Zurück zum Zitat Hüttner FJ, Koessler-Ebs J, Hackert T, et al. Meta-analysis of surgical outcome after enucleation versus standard resection for pancreatic neoplasms. Br J Surg 2015;102(9):1026–1036CrossRefPubMed Hüttner FJ, Koessler-Ebs J, Hackert T, et al. Meta-analysis of surgical outcome after enucleation versus standard resection for pancreatic neoplasms. Br J Surg 2015;102(9):1026–1036CrossRefPubMed
42.
Zurück zum Zitat Beger HG, Siech M, Poch B, et al. Limited surgery for benign tumours of the pancreas: a systematic review. World J Surg 2015;39:1557–1566.CrossRefPubMed Beger HG, Siech M, Poch B, et al. Limited surgery for benign tumours of the pancreas: a systematic review. World J Surg 2015;39:1557–1566.CrossRefPubMed
43.
Zurück zum Zitat Crippa S, Bassi C, Warshaw AL, Falconi M, Partelli S, Thayer SP, et al. Middle pancreatectomy: indications, short- and long-term operative outcomes Ann Surg 2007;246:69–76.CrossRefPubMedPubMedCentral Crippa S, Bassi C, Warshaw AL, Falconi M, Partelli S, Thayer SP, et al. Middle pancreatectomy: indications, short- and long-term operative outcomes Ann Surg 2007;246:69–76.CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat DiNorcia J, Ahmed L, Lee MK, et al. Better preservation of endocrine function after central versus distal pancreatectomy for mid-gland lesions. Surgery 2010;148:1247–1256;CrossRefPubMed DiNorcia J, Ahmed L, Lee MK, et al. Better preservation of endocrine function after central versus distal pancreatectomy for mid-gland lesions. Surgery 2010;148:1247–1256;CrossRefPubMed
45.
Zurück zum Zitat Beger HG, Gansauge F, Siech M, Schwarz M, Poch B. Duodenum-preserving total pancreatic head resection for cystic neoplastic lesions in the head of the pancreas. J Hepatobiliary Pancreat Surg. 2008;15:149–56.CrossRefPubMed Beger HG, Gansauge F, Siech M, Schwarz M, Poch B. Duodenum-preserving total pancreatic head resection for cystic neoplastic lesions in the head of the pancreas. J Hepatobiliary Pancreat Surg. 2008;15:149–56.CrossRefPubMed
46.
Zurück zum Zitat Beger HG, Mayer B, Rau BM. Parenchyma-Sparing, Limited Pancreatic Head Resection for Benign Tumors and Low-Risk Periampullary Cancer—a Systematic Review. J Gastrointest Surg 2016;20:206–217.CrossRefPubMed Beger HG, Mayer B, Rau BM. Parenchyma-Sparing, Limited Pancreatic Head Resection for Benign Tumors and Low-Risk Periampullary Cancer—a Systematic Review. J Gastrointest Surg 2016;20:206–217.CrossRefPubMed
47.
Zurück zum Zitat Beger HG, Nakao A, Mayer B. et al. Duodenum-preserving total and partial pancreatic head resection for benign tumors – Systematic review and meta-analysis. Pancreatology 2015;15:167–178CrossRefPubMed Beger HG, Nakao A, Mayer B. et al. Duodenum-preserving total and partial pancreatic head resection for benign tumors – Systematic review and meta-analysis. Pancreatology 2015;15:167–178CrossRefPubMed
48.
Zurück zum Zitat Fujii T, Kanda M, Kodera Y, Nagai S, Sahin TT, et al. Comparison of pancreatic head resection with segmental duodenectomy and pylorus-preserving pancreatoduodenectomy for benign and low-grade malignant neoplasms of the pancreatic head. Pancreas. 2011;40:1258–1263.CrossRefPubMed Fujii T, Kanda M, Kodera Y, Nagai S, Sahin TT, et al. Comparison of pancreatic head resection with segmental duodenectomy and pylorus-preserving pancreatoduodenectomy for benign and low-grade malignant neoplasms of the pancreatic head. Pancreas. 2011;40:1258–1263.CrossRefPubMed
Metadaten
Titel
Benign Tumors of the Pancreas—Radical Surgery Versus Parenchyma-Sparing Local Resection—the Challenge Facing Surgeons
verfasst von
Hans G. Beger
Publikationsdatum
03.01.2018
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 3/2018
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-017-3644-2

Weitere Artikel der Ausgabe 3/2018

Journal of Gastrointestinal Surgery 3/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.